Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization.
Lykins WR, Pollet J, White JA, Keegan B, Versteeg L, Strych U, Chen WH, Mohamath R, Ramer-Denisoff G, Reed S, Renshaw C, Beaver S, Gerhardt A, Voigt EA, Tomai MA, Sitrin R, Choy RKM, Cassels FJ, Hotez PJ, Bottazzi ME, Fox CB.
Lykins WR, et al. Among authors: white ja.
Front Immunol. 2024 Dec 16;15:1480976. doi: 10.3389/fimmu.2024.1480976. eCollection 2024.
Front Immunol. 2024.
PMID: 39737197
Free PMC article.